Overview
ARMP market data
Price History
ARMP price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for ARMP. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Why Is Armata Pharma Stock Gaining Monday?Benzinga · Jul 20, 2026, 4:45 PM
Armata Pharmaceuticals shares are trading higher after the company reported clinical, regulatory, manufacturing, and operational progress advancing AP‑SA02 toward a planned Phase 3 study in complicated Staphylococcus aureus bacteremia.Benzinga · Jul 20, 2026, 2:35 PM
Armata Pharma Promotes David House To CFOBenzinga · Jul 20, 2026, 11:13 AM
8-K filing — Armata Pharmaceuticals, Inc. (ARMP)SEC EDGAR · Jul 20, 2026, 11:13 AM
Armata Announces Significant Clinical, Regulatory, Manufacturing And Operational Progress Supporting Advancement Of AP-SA02 Toward Planned Phase 3 Superiority Study For Adjunct Treatment Of Complicated BacteremiaBenzinga · Jul 20, 2026, 11:12 AM
Armata Pharma Receives Agreement From FDA On Agreed Initial Pediatric Study PlanBenzinga · Jul 13, 2026, 11:14 AM
8-K/A filing — Armata Pharmaceuticals, Inc. (ARMP)SEC EDGAR · Jun 24, 2026, 8:19 PM
Armata Pharma Receives Additional $2.5M Of Non-Dilutive DoD Funding Via Medical Technology Enterprise Consortium, Managed By Naval Medical Research CommandBenzinga · Jun 23, 2026, 11:20 AM
Armata Pharmaceuticals Q1 EPS $(3.16) Misses $(0.38) Estimate, Sales $789.000K Up From $491.000K YoYBenzinga · May 13, 2026, 8:42 PM